Fortis Healthcare (FORTIS) 52 Week Low Streak: Why the decline persisted

Fortis Healthcare Ltd. has now set a fresh 52-week low for its second straight session, extending a streak that has taken the stock down 8.42% across the run. The latest trough is Rs 748.8, while the current price is Rs 750.05. Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.

The company’s market capitalisation stands at Rs 61,831.07 crore, which places the current move in a large listed healthcare business rather than a smaller, thinly followed counter. For readers, the key difference versus a one-day breakdown is repetition: Fortis Healthcare 52 Week Low Streak now reflects consecutive weakness, not just a single-session slip, and that changes how the price action should be read.

Fortis Healthcare Ltd. 52 Week Low Streak: Consecutive Low Analysis

Metric	Value
Current Price	Rs 750.05
Previous Close	Rs 768.2
Today's Move	Rs -18.15 (-2.36%)
Open	Rs 764.9
High	Rs 764.9
Low	Rs 748.8
Market Capitalisation	Rs 61,831.07 crore

Fortis Healthcare Ltd. (FORTIS) traded at Rs 750.05 versus the previous close of Rs 768.2, a fall of 2.36%. The stock opened at Rs 764.9, reached a high of Rs 764.9, touched a low of Rs 748.8.

Fortis Healthcare Ltd. closed at Rs 750.05 versus the previous close of Rs 768.2, a decline of Rs 18.15 or 2.36% on the day. The stock opened at Rs 764.9, matched its day high at Rs 764.9 and then slipped to a low of Rs 748.8, which also marks the fresh 52-week low. That means the close finished very near the session trough, keeping Fortis Healthcare 52 Week Low Streak in focus.

The close sat below the opening level and just above the low of the day, which shows that the latest session ended with the stock still near its weakest point. The market capitalisation of Rs 61,831.07 crore keeps Fortis Healthcare 52 Week Low Streak in the spotlight as a notable large-cap healthcare name. The current share price, the day’s fall and the repeated yearly low together show that the breakdown has extended beyond one trading day.

What the Repeated 52-Week Lows Show

Fortis Healthcare 52 Week Low Streak now spans two consecutive sessions, and that is the most important fact in the current setup. The stock has not only printed a fresh yearly low once; it has done so again, which means the decline has persisted rather than reversed. The cumulative decline of 8.42% across the streak is more informative than any single-day change because it captures the whole run.

For the current streak, the latest low of Rs 748.8 is the same level as the day’s low, so there is no gap between the session trough and the 52-week low. As a result, Fortis Healthcare 52 Week Low Streak now points to a repeated pattern of lower pricing across back-to-back sessions. The latest Univest data confirms the pattern, but it does not identify a company-specific trigger, and that distinction matters for readers tracking the move.

In practical terms, Fortis Healthcare 52 Week Low Streak suggests that the stock has remained under pressure long enough for the market to keep repricing it lower on more than one day. The current run should therefore be read as an extended decline rather than an isolated reset in the share price.

Fortis Healthcare Ltd. (FORTIS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 61,831.07 crore
P/E Ratio	55.35x
P/B Ratio	5.71x
ROE	11.32%
ROCE	14.07%
EPS	Rs 13.88
Book Value Per Share	Rs 134.61
Dividend Yield	0.13%

Fortis Healthcare Ltd. (FORTIS) fundamental metrics show P/E 55.35x, P/B 5.71x, ROE 11.32%, ROCE 14.07%. Taken on their own, these numbers offer context rather than a trading signal.

Fortis Healthcare Ltd. has a market capitalisation of Rs 61,831.07 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.35x, P/B at 5.71x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.32% and ROCE of 14.07%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 13.88, book value per share of Rs 134.61, dividend yield of 0.13%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 45.44x, median ROE of 13.07%, median ROCE of 15.86%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	55.35x
Benchmark Median P/E	45.44x
Benchmark Average P/E	100.45x
Benchmark P/E Range	6.96x to 1,608.25x
Company P/B Ratio	5.71x
Benchmark Median P/B	3.75x
Company ROE	11.32%
Benchmark Median ROE	13.07%
Company ROCE	14.07%
Benchmark Median ROCE	15.86%
Company Market Capitalisation	Rs 61,831.07 crore
Benchmark Median Market Cap	Rs 558.66 crore

Fortis Healthcare Ltd. (FORTIS) operates in the Healthcare sector, within the Hospital & Healthcare Services industry.

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 55.35x, which is above the benchmark median of 45.44x, a difference of +21.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Fortis Healthcare Ltd. (FORTIS) has a ROE of 11.32%, which is below the benchmark median of 13.07%, a difference of -13.39%. Fortis Healthcare Ltd. (FORTIS) has a ROCE of 14.07%, which is below the benchmark median of 15.86%, a difference of -11.29%.

Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aster DM Healthcare Ltd.	ASTERDM	64,094.07	190.26	14.33	13.07	16.22
Max Healthcare Institute Ltd.	MAXHEALTH	95,768.86	62.11	8.28	14.53	14.97
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	98,508.6	104.47	5.11	12.95	13.93
Global Health Ltd.	MEDANTA	38,059.23	65.97	8.92	15.12	19.38
Narayana Hrudayalaya Ltd.	NH	36,850.34	44.89	7.72	19.86	16.2

Fortis Healthcare Ltd. (FORTIS) has a P/E ratio of 55.35x compared with the displayed peer median of 65.97x. The comparison is relative and should not be read as a recommendation. Its ROE of 11.32% compares with a peer median of 14.53% across the companies shown in the table. ROCE stood at 14.07% versus the displayed peer median of 16.2%, providing a capital-efficiency comparison. Fortis Healthcare Ltd. (FORTIS) has a market capitalisation of Rs 61,831.07 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching

• Fortis Healthcare 52 Week Low Streak now covers two consecutive sessions, so the repeated-low pattern is more important than one day’s move.
• The cumulative decline of 8.42% across the streak gives a clearer read on the full drop than the latest daily change alone.
• The stock’s P/E of 55.35 and P/B of 5.71 remain above the healthcare industry median, even after the slide.
• ROE at 11.32% and ROCE at 14.07% sit below the industry median, which adds context to the valuation discussion.
• The latest low is Rs 748.8, so any further move lower would extend Fortis Healthcare 52 Week Low Streak into a deeper yearly trough zone.

About the Company

Fortis Healthcare Ltd. operates in the Hospital & Healthcare Services space within the Healthcare sector. For readers tracking Fortis Healthcare 52 Week Low Streak, the important business context is that the company is a sizeable listed healthcare operator with a market capitalisation of Rs 61,831.07 crore and a visible presence in the sector benchmark set.

The current financial profile shows EPS of Rs 13.88, book value of Rs 134.61, ROE of 11.32% and ROCE of 14.07%. Those figures matter because Fortis Healthcare 52 Week Low Streak is happening against a backdrop of established operating metrics, not against an unknown business base. That makes the streak a valuation and market-price event rather than a change in the company’s reported fundamentals.

Track Fortis Healthcare Share Price on Univest

Use Fortis Healthcare Ltd. (FORTIS) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.

For readers following Fortis Healthcare 52 Week Low Streak, the share price page can help you keep track of the latest price, daily change and valuation inputs in one place. The current move should be monitored alongside the broader price pattern rather than viewed as a single-session event.

Fortis Healthcare 52 Week Low Streak remains the key framing for the stock at this point, because the repeat low matters more than the latest print alone. Investors tracking the stock should watch whether the next session confirms another low or stabilises the move.

Frequently Asked Questions

What does Fortis Healthcare 52 Week Low Streak mean?

Ans. It means Fortis Healthcare has set a fresh 52-week low in consecutive sessions. In this case, the streak has reached a second straight session, which shows a repeated decline rather than a one-day move.

How many sessions has Fortis Healthcare 52 Week Low Streak lasted?

Ans. Fortis Healthcare 52 Week Low Streak has lasted for two consecutive trading sessions. The stock has made a fresh one-year low on each of those sessions, according to latest Univest data.

What is the cumulative decline across Fortis Healthcare 52 Week Low Streak?

Ans. The cumulative decline across Fortis Healthcare 52 Week Low Streak is 8.42%. That figure captures the full move across the two-session run and is more useful than the latest daily change alone.

What is the latest 52-week low for Fortis Healthcare?

Ans. The latest 52-week low for Fortis Healthcare is Rs 748.8. The current price of Rs 750.05 is just above that trough, so the stock remains close to its fresh yearly low.

Does the data confirm why Fortis Healthcare 52 Week Low Streak continued?

Ans. No. The latest Univest data confirms the repeated low pattern, but it does not establish a company-specific cause for the continued decline. Readers should treat the streak as a confirmed price pattern, not a confirmed reason.

How does Fortis Healthcare compare with its healthcare peers?

Ans. Fortis Healthcare trades at a P/E of 55.35 and a P/B of 5.71, which places it above some peers and below others. It remains above the industry median on both valuation measures even after Fortis Healthcare 52 Week Low Streak.

Is Fortis Healthcare lower-valued after the streak?

Ans. The share price is lower, but the valuation is still not below the peer median on both P/E and P/B. Fortis Healthcare 52 Week Low Streak has reduced the price, yet the stock still trades at a premium to the.

What fundamentals are most relevant for Fortis Healthcare 52 Week Low Streak?

Ans. Key figures are P/E, P/B, ROE, ROCE, EPS and book value. For this streak, the important point is that earnings and book value have not changed across the run, so the valuation shift comes from the price decline.

What should investors monitor next for Fortis Healthcare?

Ans. Investors should watch whether the stock sets another fresh 52-week low or stabilises above the latest trough. For Fortis Healthcare 52 Week Low Streak, the next session will show whether the repeated decline continues or pauses.